<p>Sherbrooke Park Advisers LLC 在第四季度购买了 Medtronic plc (NYSE:MDT - 免费报告) 的新股份，根据其最近向证券交易委员会提交的 13F 表格。该公司购买了 12,553 股医疗技术公司的股票，价值约为 1,003,000 美元。</p>
<ul>
<li>Medtronic：一只稳定且具创新性的股息贵族</li>
</ul>
<p>其他一些对冲基金最近也对 MDT 的持仓进行了调整。Mainstream Capital Management LLC 在第四季度以 26,000 美元的价格购买了 Medtronic 的新股份。Rakuten Securities Inc. 在第四季度将其在 Medtronic 的持股增加了 753.8%。Rakuten Securities Inc. 目前拥有 333 股医疗技术公司的股票，价值 27,000 美元，此前在上个季度又购买了 294 股。Stephens Consulting LLC 在第四季度将其在 Medtronic 的持股增加了 145.7%。Stephens Consulting LLC 目前拥有 344 股医疗技术公司的股票，价值 27,000 美元，此前在上个季度又收购了 204 股。Optiver Holding B.V. 在第四季度以约 31,000 美元的价格购买了 Medtronic 的新股份。最后，Chapman Financial Group LLC 在第四季度以约 33,000 美元的价格购买了 Medtronic 的新股份。目前，82.06% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>分析师评级变动</h2>
<p>MDT 最近成为几份研究报告的主题。Robert W. Baird 在 2 月 19 日的报告中将 Medtronic 的股票目标价从 90.00 美元上调至 91.00 美元，并给予该股票 &#34;中性&#34; 评级。Truist Financial 在 4 月 11 日的报告中将 Medtronic 的目标价从 93.00 美元下调至 90.00 美元，并对该股票设定了 &#34;持有&#34; 评级。Needham &amp; Company LLC 在 2 月 19 日的研究报告中重申了对 Medtronic 股票的 &#34;持有&#34; 评级。Citigroup 在 3 月 4 日的研究报告中将 Medtronic 的评级从 &#34;中性&#34; 上调至 &#34;买入&#34;，并将该股票的目标价从 92.00 美元上调至 107.00 美元。最后，加拿大皇家银行在 2 月 19 日的研究报告中重申了 &#34;跑赢大盘&#34; 的评级，并对 Medtronic 股票设定了 105.00 美元的目标价。一位分析师对该股票给予了卖出评级，八位分析师给予了持有评级，六位分析师给予了买入评级，还有一位分析师给予了强烈买入评级。根据 MarketBeat.com 的数据，Medtronic 目前的平均评级为 &#34;持有&#34;，共识目标价为 96.14 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 02/17 - 02/21</li>
</ul>
<p><strong>获取我们关于 MDT 的最新研究报告</strong></p>
<h2>Medtronic 股价上涨 2.0%</h2>
<p>周五，NYSE MDT 的开盘价为 85.96 美元。该公司的债务与股本比率为 0.48，速动比率为 1.39，流动比率为 1.90。该公司的市值为 1,102.5 亿美元，市盈率为 26.13，PEG 比率为 2.22，贝塔值为 0.81。该公司的 50 日简单移动平均线为 86.07 美元，200 日简单移动平均线为 86.67 美元。Medtronic plc 的一年低点为 75.96 美元，一年高点为 96.25 美元。</p>
<ul>
<li>Medtronic 的扩张势头增强——市场转变的时机到了吗？</li>
</ul>
<p>Medtronic (NYSE:MDT - 获取免费报告) 最近在 2 月 18 日发布了其财报。该医疗技术公司报告本季度每股收益为 1.39 美元，超出市场共识预期的 1.36 美元，超出 0.03 美元。该公司本季度的收入为 82.9 亿美元，而分析师预期为 83.3 亿美元。Medtronic 的股本回报率为 14.07%，净利润率为 12.83%。股票研究分析师预计 Medtronic plc 本财年的每股收益将达到 5.46 美元。</p>
<h2>Medtronic 股息公告</h2>
<p>该公司最近还宣布了季度股息，已于 4 月 11 日支付。3 月 28 日的股东获得了每股 0.70 美元的股息。除息日期为 3 月 28 日。这代表着年化股息为 2.80 美元，股息收益率为 3.26%。Medtronic 的股息支付比率 (DPR) 目前为 85.11%。</p>
<h2>Medtronic 公司简介</h2>
<p>(免费报告)</p>
<p>Medtronic plc 开发、制造并销售基于设备的医疗疗法，面向全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Medtronic</li>
<li>现在购买的三只最佳金融科技股票</li>
<li>三只小盘股，尽管面临关税逆风，仍有上涨空间</li>
<li>三只沃伦·巴菲特的股票，值得现在购买</li>
<li>CRSPR 股票可能准备兑现其巨大的承诺</li>
<li>现在购买的一些最佳大盘股是什么？</li>
<li>分析师和机构继续大举押注 Alphabet</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Medtronic 吗？</h2>
<p>在考虑 Medtronic 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Medtronic 并不在名单上。</p>
<p>虽然 Medtronic 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美敦力

<p>Sherbrooke Park Advisers LLC 在第四季度收购了 12,553 股美敦力（Medtronic plc，NYSE:MDT），价值约为 1,003,000 美元，根据最近的 SEC 文件显示。其他对冲基金也增加了对美敦力的持股。分析师对 MDT 的评级显示出持有和买入评级的混合，普遍目标价为 96.14 美元。美敦力最近报告的每股收益为 1.39 美元，超出预期，并宣布每股季度分红为 0.70 美元，反映出 3.26% 的收益率</p>

<p>Sherbrooke Park Advisers LLC purchased a new stake in Medtronic plc (NYSE:MDT - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 12,553 shares of the medical technology company's stock, valued at approximately $1,003,000.</p>
<div class="lb-trans"><p>Sherbrooke Park Advisers LLC 在第四季度购买了 Medtronic plc (NYSE:MDT - 免费报告) 的新股份，根据其最近向证券交易委员会提交的 13F 表格。该公司购买了 12,553 股医疗技术公司的股票，价值约为 1,003,000 美元。</p>
</div><ul>
<li>Medtronic: A Dividend Aristocrat With Stability and Innovation</li>
</ul>
<div class="lb-trans"><ul>
<li>Medtronic：一只稳定且具创新性的股息贵族</li>
</ul>
</div><p>A number of other hedge funds have also recently made changes to their positions in MDT. Mainstream Capital Management LLC bought a new position in shares of Medtronic during the 4th quarter valued at $26,000. Rakuten Securities Inc. grew its holdings in shares of Medtronic by 753.8% in the fourth quarter. Rakuten Securities Inc. now owns 333 shares of the medical technology company's stock worth $27,000 after purchasing an additional 294 shares during the last quarter. Stephens Consulting LLC grew its holdings in Medtronic by 145.7% in the 4th quarter. Stephens Consulting LLC now owns 344 shares of the medical technology company's stock worth $27,000 after acquiring an additional 204 shares during the last quarter. Optiver Holding B.V. purchased a new position in shares of Medtronic in the fourth quarter valued at about $31,000. Finally, Chapman Financial Group LLC bought a new position in shares of Medtronic during the fourth quarter valued at about $33,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他一些对冲基金最近也对 MDT 的持仓进行了调整。Mainstream Capital Management LLC 在第四季度以 26,000 美元的价格购买了 Medtronic 的新股份。Rakuten Securities Inc. 在第四季度将其在 Medtronic 的持股增加了 753.8%。Rakuten Securities Inc. 目前拥有 333 股医疗技术公司的股票，价值 27,000 美元，此前在上个季度又购买了 294 股。Stephens Consulting LLC 在第四季度将其在 Medtronic 的持股增加了 145.7%。Stephens Consulting LLC 目前拥有 344 股医疗技术公司的股票，价值 27,000 美元，此前在上个季度又收购了 204 股。Optiver Holding B.V. 在第四季度以约 31,000 美元的价格购买了 Medtronic 的新股份。最后，Chapman Financial Group LLC 在第四季度以约 33,000 美元的价格购买了 Medtronic 的新股份。目前，82.06% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>MDT has been the subject of several research reports. Robert W. Baird upped their price objective on shares of Medtronic from $90.00 to $91.00 and gave the stock a &#34;neutral&#34; rating in a report on Wednesday, February 19th. Truist Financial reduced their target price on Medtronic from $93.00 to $90.00 and set a &#34;hold&#34; rating on the stock in a report on Friday, April 11th. Needham &amp; Company LLC restated a &#34;hold&#34; rating on shares of Medtronic in a research note on Wednesday, February 19th. Citigroup raised Medtronic from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and upped their price target for the stock from $92.00 to $107.00 in a research note on Tuesday, March 4th. Finally, Royal Bank of Canada reaffirmed an &#34;outperform&#34; rating and issued a $105.00 target price on shares of Medtronic in a research report on Wednesday, February 19th. One analyst has rated the stock with a sell rating, eight have given a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, Medtronic currently has an average rating of &#34;Hold&#34; and a consensus price target of $96.14.</p>
<div class="lb-trans"><p>MDT 最近成为几份研究报告的主题。Robert W. Baird 在 2 月 19 日的报告中将 Medtronic 的股票目标价从 90.00 美元上调至 91.00 美元，并给予该股票 &#34;中性&#34; 评级。Truist Financial 在 4 月 11 日的报告中将 Medtronic 的目标价从 93.00 美元下调至 90.00 美元，并对该股票设定了 &#34;持有&#34; 评级。Needham &amp; Company LLC 在 2 月 19 日的研究报告中重申了对 Medtronic 股票的 &#34;持有&#34; 评级。Citigroup 在 3 月 4 日的研究报告中将 Medtronic 的评级从 &#34;中性&#34; 上调至 &#34;买入&#34;，并将该股票的目标价从 92.00 美元上调至 107.00 美元。最后，加拿大皇家银行在 2 月 19 日的研究报告中重申了 &#34;跑赢大盘&#34; 的评级，并对 Medtronic 股票设定了 105.00 美元的目标价。一位分析师对该股票给予了卖出评级，八位分析师给予了持有评级，六位分析师给予了买入评级，还有一位分析师给予了强烈买入评级。根据 MarketBeat.com 的数据，Medtronic 目前的平均评级为 &#34;持有&#34;，共识目标价为 96.14 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 02/17 - 02/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 02/17 - 02/21</li>
</ul>
</div><p><strong>Get Our Latest Research Report on MDT</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 MDT 的最新研究报告</strong></p>
</div><h2>Medtronic Trading Up 2.0%</h2>
<div class="lb-trans"><h2>Medtronic 股价上涨 2.0%</h2>
</div><p>NYSE MDT opened at $85.96 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.39 and a current ratio of 1.90. The firm has a market cap of $110.25 billion, a price-to-earnings ratio of 26.13, a PEG ratio of 2.22 and a beta of 0.81. The firm has a 50 day simple moving average of $86.07 and a 200-day simple moving average of $86.67. Medtronic plc has a one year low of $75.96 and a one year high of $96.25.</p>
<div class="lb-trans"><p>周五，NYSE MDT 的开盘价为 85.96 美元。该公司的债务与股本比率为 0.48，速动比率为 1.39，流动比率为 1.90。该公司的市值为 1,102.5 亿美元，市盈率为 26.13，PEG 比率为 2.22，贝塔值为 0.81。该公司的 50 日简单移动平均线为 86.07 美元，200 日简单移动平均线为 86.67 美元。Medtronic plc 的一年低点为 75.96 美元，一年高点为 96.25 美元。</p>
</div><ul>
<li>Medtronic’s Expansion Gains Momentum—Time for a Market Shift?</li>
</ul>
<div class="lb-trans"><ul>
<li>Medtronic 的扩张势头增强——市场转变的时机到了吗？</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last posted its earnings results on Tuesday, February 18th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.36 by $0.03. The firm had revenue of $8.29 billion for the quarter, compared to analyst estimates of $8.33 billion. Medtronic had a return on equity of 14.07% and a net margin of 12.83%. Equities research analysts anticipate that Medtronic plc will post 5.46 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Medtronic (NYSE:MDT - 获取免费报告) 最近在 2 月 18 日发布了其财报。该医疗技术公司报告本季度每股收益为 1.39 美元，超出市场共识预期的 1.36 美元，超出 0.03 美元。该公司本季度的收入为 82.9 亿美元，而分析师预期为 83.3 亿美元。Medtronic 的股本回报率为 14.07%，净利润率为 12.83%。股票研究分析师预计 Medtronic plc 本财年的每股收益将达到 5.46 美元。</p>
</div><h2>Medtronic Dividend Announcement</h2>
<div class="lb-trans"><h2>Medtronic 股息公告</h2>
</div><p>The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a dividend of $0.70 per share. The ex-dividend date was Friday, March 28th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 3.26%. Medtronic's dividend payout ratio (DPR) is presently 85.11%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度股息，已于 4 月 11 日支付。3 月 28 日的股东获得了每股 0.70 美元的股息。除息日期为 3 月 28 日。这代表着年化股息为 2.80 美元，股息收益率为 3.26%。Medtronic 的股息支付比率 (DPR) 目前为 85.11%。</p>
</div><h2>Medtronic Company Profile</h2>
<div class="lb-trans"><h2>Medtronic 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p>
<div class="lb-trans"><p>Medtronic plc 开发、制造并销售基于设备的医疗疗法，面向全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>The 3 Best Fintech Stocks to Buy Now</li>
<li>3 Small-Cap Stocks With Room to Run Despite Tariff Headwinds</li>
<li>3 Warren Buffett Stocks to Buy Now</li>
<li>CRSPR Stock Could Be Ready to Deliver on Its Massive Promise</li>
<li>What Are Some of the Best Large-Cap Stocks to Buy?</li>
<li>Analysts and Institutions Continue to Bet Big on Alphabet</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Medtronic</li>
<li>现在购买的三只最佳金融科技股票</li>
<li>三只小盘股，尽管面临关税逆风，仍有上涨空间</li>
<li>三只沃伦·巴菲特的股票，值得现在购买</li>
<li>CRSPR 股票可能准备兑现其巨大的承诺</li>
<li>现在购买的一些最佳大盘股是什么？</li>
<li>分析师和机构继续大举押注 Alphabet</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Medtronic 吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Medtronic 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Medtronic 并不在名单上。</p>
</div><p>While Medtronic currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Medtronic 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Sherbrooke Park Advisers LLC 收购了美敦力公司（NYSE: MDT）的 12,553 股股票